Pulsed Nitric Oxide Delivery Device for Toxic Byproduct Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for delivering nitric oxide pose risks such as the formation of toxic byproducts, methemoglobinemia, and a 'rebound' effect due to continuous inhalation, particularly with high concentrations, necessitating a safer delivery method.

Innovation Solution

A pulsed or intermittent delivery of nitric oxide interspersed with breaths of oxygen-enriched air, using a device with separate or combined delivery tubes and a NO generation cartridge that converts NO2 to NO, with antioxidants like ascorbic acid or tocopherols, allowing for controlled and safe administration of high concentrations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If continuous inhalation of high concentration nitric oxide is used, then therapeutic effect is improved, but toxic reactions and rebound effects increase

Engineering Contradiction:
Improvetherapeutic effectVSAvoidtoxic reactions
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies periodic action by delivering nitric oxide in intermittent pulses rather than continuously. The device alternates between delivering high concentration NO (200-1000 ppm) for short periods and delivering oxygen-enriched air or placebo, creating a pulsed delivery pattern that maintains therapeutic effectiveness while reducing cumulative toxic exposure and preventing rebound effects

Inventive Principle:
Principle #19Periodic action

2Reliability

If high concentration nitric oxide is delivered, then therapeutic effectiveness is improved, but formation of toxic byproducts increases

Engineering Contradiction:
Improvetherapeutic effectivenessVSAvoidtoxic byproducts
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The periodic delivery pattern allows high concentration NO to be delivered at therapeutic levels while the intermittent oxygen-enriched air periods prevent excessive oxidation that would otherwise convert NO to toxic nitrogen dioxide (NO2) byproducts

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

Oxygen-enriched air serves as an intermediary substance that alternates with nitric oxide delivery. This intermediary prevents direct continuous exposure to high NO concentrations, reducing the chemical reactions that produce toxic byproducts while maintaining therapeutic benefits through the pulsed delivery pattern

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If continuous nitric oxide inhalation is used, then therapeutic benefit is maintained, but rebound effect occurs

Engineering Contradiction:
Improvetherapeutic benefitVSAvoidrebound effect
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The intermittent pulsed delivery prevents the development of rebound effects by avoiding continuous exposure. The alternating periods of oxygen-enriched air allow the pulmonary vasculature to maintain normal tone between NO pulses, preventing the compensatory vasoconstriction that occurs with continuous delivery

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

The oxygen-enriched air periods serve as a preliminary anti-action that counteracts potential rebound vasoconstriction before it can occur. By periodically introducing oxygen-rich breaths, the system preemptively maintains vascular health and prevents the development of rebound effects

Inventive Principle:
Principle #9Preliminary anti-action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method reduces toxic reactions and potential 'rebound' effects by alternating nitric oxide and oxygen delivery, ensuring safe and effective treatment with reduced risks of NO2 formation and methemoglobinemia, enabling the use of higher concentrations without adverse effects.

Implementation Method 1

generating nitric oxide by exposing nitrogen dioxide to an antioxidant

Methodology Applied
Scientific EffectChemical reaction: Redox Reactions

Implementation Method 2

a surface activated material saturated with an antioxidant

Methodology Applied
Scientific EffectAbsorption: Absorption (physical)

Data Source

PatentUS10960168B2Delivery of high concentration nitric oxide
Publication Date: 2021.03.30 VERO BIOTECH INC
  • US10960168B2 patent drawing
  • US10960168B2 patent drawing

AI summary

A method and device can alternately deliver high concentration of nitric oxide and oxygen-enriched air. A method of providing a therapeutic amount of nitric oxide to a mammal can include delivering one or more breaths of a therapeutic amount of nitric oxide to the mammal and delivering one or more breaths of an amount of oxygen-enriched air to the mammal immediately after the one or more breaths of the therapeutic amount of nitric oxide.